Form D · Biotechnology
Galaxy Medical, Inc.
San Carlos, CA · CIK 0001808216
Offering snapshot reported Nov 10, 2021 · SEC filing
- Reported sold
- $750K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2021 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Oct 4, 2021 | Initial | $1,250,000 | No comparison | 1 | SEC filing |
| Oct 29, 2020 | Amendment | $8,000,000 | $7,800,000vs Apr 1, 2020 | 1 | SEC filing |
| Apr 1, 2020 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420659
Source: Form D, filed Nov 10, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Seth Harrison | Director |
| Jonathan Waldstreicher | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1531 Industrial Rd
San Carlos, CA, 94070
San Carlos, CA, 94070